Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$84.80
pos +0.00
+0.00%
Today's Range: 84.42 - 85.42 | ESRX Avg Daily Volume: 3,893,700
Last Update: 01/23/15 - 3:59 PM EST
Volume: 0
YTD Performance: 0.15%
Open: $0.00
Previous Close: $84.99
52 Week Range: $64.64 - $86.64
Oustanding Shares: 733,910,000
Market Cap: 62,375,010,900
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 3 3 3 2
Hold 5 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.55 1.55 1.53
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 34.00
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
34.00 34.10 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.07% 13.93% 64.15%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.38 $1.15 $4.88 $5.44
Number of Analysts 14 9 16 16
High Estimate $1.40 $1.21 $4.90 $5.55
Low Estimate $1.37 $1.11 $4.87 $5.35
Prior Year $1.12 $0.99 $4.33 $4.88
Growth Rate (Year over Year) 23.47% 16.50% 12.70% 11.55%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

A Tale of Two Drugstores Real Money Pro($)

For Walgreen, 2012's bad news was good news, while CVS remains an attractive investment choice.
Bullish
Feb 28, 2013 | 8:17 AM EST
ESRX estimates were boosted through 2014, Citigroup said. Company is keeping a tight lid on costs. Buy rating and new $64 price target....
These two solid names are finding support at their longer-term moving averages.
Bullish
Feb 20, 2013 | 7:57 AM EST
Shares of ESRX now seen reaching $65, according to Lazard Capital Markets. Estimates also upped, given better operating trends. Buy rat...
It’s much tougher to actually “buy low to sell high” than it is to espouse the concept.

Value Seekers, Don't Chase Real Money Pro($)

ESRX still has a a historically low valuation.

Three Names to Watch Real Money Pro($)

This market is rewarding finding the trade early.

More From the Street of Dreams Real Money Pro($)

BofA bumps up earnings estimates for Express Scripts.
How to counter the effects of a downtrending dollar.
This stock is a steady climber, and it's at a glaring entry point.

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.